Related references
Note: Only part of the references are listed.The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis
January Weiner et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
The Immune Response in Tuberculosis
Anne O'Garra et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity
Krzysztof Bryniarski et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment
Anca Dorhoi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tuberculosis biomarkers discovery: developments, needs, and challenges
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2013)
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
Satria A. Prabowo et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MicroRNA Expression Profile of Mouse Lung Infected with 2009 Pandemic H1N1 Influenza Virus
Zhihao Wu et al.
PLOS ONE (2013)
miRNA Signatures in Sera of Patients with Active Pulmonary Tuberculosis
Paolo Miotto et al.
PLOS ONE (2013)
Synthesis and delivery of short, noncoding RNA by B lymphocytes
Gonzalo Almanza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Functional screening identifies miRNAs inducing cardiac regeneration
Ana Eulalio et al.
NATURE (2012)
Altered microRNA Signatures in Sputum of Patients with Active Pulmonary Tuberculosis
Zhengjun Yi et al.
PLOS ONE (2012)
Common patterns and disease-related signatures in tuberculosis and sarcoidosis
Jeroen Maertzdorf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The mammalian microRNA response to bacterial infections
Ana Eulalio et al.
RNA BIOLOGY (2012)
Circulating MicroRNAs in Patients with Active Pulmonary Tuberculosis
Yurong Fu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ
Feng Ma et al.
NATURE IMMUNOLOGY (2011)
Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b
Murugesan V. S. Rajaram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Local pulmonary immunotherapy with siRNA targeting TGF beta 1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice
Adrian G. Rosas-Taraco et al.
TUBERCULOSIS (2011)
Reduced miR-146a Increases Prostaglandin E2 in Chronic Obstructive Pulmonary Disease Fibroblasts
Tadashi Sato et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Regression of murine lung tumors by the let-7 microRNA
P. Trang et al.
ONCOGENE (2010)
Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids
Sterghios A. Moschos et al.
BMC GENOMICS (2007)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
Share Paper
